Evidence map›Paper›PMID 28157489›Full record

ArticleThe American journal of pathology2017

Cathepsin H-Mediated Degradation of HDAC4 for Matrix Metalloproteinase Expression in Hepatic Stellate Cells: Implications of Epigenetic Suppression of Matrix Metalloproteinases in Fibrosis through Stabilization of Class IIa Histone Deacetylases.

Zemin Yang, Yu Liu, Lan Qin, Pengfei Wu, Zanxian Xia, Mei Luo, Yilan Zeng, Hidekazu Tsukamoto, Zongyun Ju, Danmei Su and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Extracellular Matrix Regulation in Physiology and in Brain Disease.International journal of molecular sciences · 2023
    Review
  6. PPARAmerican journal of physiology. Gastrointestinal and liver physiology · 2021
    Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. miR-149-5p Inhibits Vascular Smooth Muscle Cells Proliferation, Invasion, and Migration by Targeting Histone Deacetylase 4 (HDAC4).Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 2 countries.

Zemin YangThe Center for Growth, Metabolism and Aging, and the Key Laboratory for Bio-Resource and Eco-Environment of Education of Ministry, College of Life Sciences, Sichuan University, Chengdu, China.
Yu LiuThe Center for Growth, Metabolism and Aging, and the Key Laboratory for Bio-Resource and Eco-Environment of Education of Ministry, College of Life Sciences, Sichuan University, Chengdu, China.
Lan QinDepartment of Surgery, University of Southern California, Los Angeles, California.
Pengfei WuThe Center for Growth, Metabolism and Aging, and the Key Laboratory for Bio-Resource and Eco-Environment of Education of Ministry, College of Life Sciences, Sichuan University, Chengdu, China.
Zanxian XiaState Key Laboratory of Medical Genetics & School of Life Sciences, Central South University, Changsha, China.
Mei LuoThe Center for Growth, Metabolism and Aging, and the Key Laboratory for Bio-Resource and Eco-Environment of Education of Ministry, College of Life Sciences, Sichuan University, Chengdu, China; Chengdu Public Health Clinical Center, Chengdu, China.
Yilan ZengChengdu Public Health Clinical Center, Chengdu, China.
Hidekazu TsukamotoDepartment of Surgery, University of Southern California, Los Angeles, California.
Zongyun JuChengdu Tongde Pharmaceutical Co. Ltd., Chengdu, China.
Danmei SuThe Center for Growth, Metabolism and Aging, and the Key Laboratory for Bio-Resource and Eco-Environment of Education of Ministry, College of Life Sciences, Sichuan University, Chengdu, China.
Han KangThe Center for Growth, Metabolism and Aging, and the Key Laboratory for Bio-Resource and Eco-Environment of Education of Ministry, College of Life Sciences, Sichuan University, Chengdu, China.
Zhixiong XiaoThe Center for Growth, Metabolism and Aging, and the Key Laboratory for Bio-Resource and Eco-Environment of Education of Ministry, College of Life Sciences, Sichuan University, Chengdu, China.
Sujun ZhengBeijing YouAn Hospital, Capital Medical University, Beijing, China.
Zhongping DuanBeijing YouAn Hospital, Capital Medical University, Beijing, China.
Richard HuOlive View-UCLA Medical Center, Los Angeles, California.
Qiang WangDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
Stephen J PandolDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
Yuan-Ping HanThe Center for Growth, Metabolism and Aging, and the Key Laboratory for Bio-Resource and Eco-Environment of Education of Ministry, College of Life Sciences, Sichuan University, Chengdu, China; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California. Electronic address: hanyp@scu.edu.cn.
Sichuan University · CNCedars-Sinai Medical Center · USPublic Health Clinical Center of Chengdu · CNUniversity of Southern California · USBeijing YouAn Hospital · CNCapital Medical University · CNCentral South University · CNOlive View-UCLA Medical Center · US

Funding

The Southernearch Center for ALPD and CirrhosisP50AA011999 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ANNA S. GUKOVSKAYA · 1999 to 2026
$45.8M
USC RESEARCH CENTER FOR LIVER DISEASES: PILOT PROGRAMSP30DK048522 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KAPLOWITZ, NEIL · 1995 to 2020
$21.8M
Vector and Human Acinar CoreP01DK098108 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PANDOL, STEPHEN J. · 2014 to 2018
$8.1M
NON-PARENCHYMAL LIVER CELL CORER24AA012885 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TSUKAMOTO, HIDEKAZU · 2001 to 2025
$8.1M
Targeting diet-induced promotion of Kras-initiated pancreatic adenocarcinomaP01CA163200 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PANDOL, STEPHEN J. · 2012 to 2016
$6.2M
Epigenetic Regulation of Alcoholic Liver FibrosisU01AA018663 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KISSELEVA, TATIANA, MANN, DEREK · 2010 to 2019
$3.7M
Hepatic Stellate Cell Derived MMP9 in Liver FibrogenesisR01DK069418 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HAN, YUAN-PING · 2004 to 2008
$1.5M
Molecular Mechanisms of Stellate Cell Activation in Liver FibrosisI01BX001991 · VA · VA GREATER LOS ANGELES HEALTHCARE SYSTEM · PI HIDEKAZU TSUKAMOTO · 2014 to 2026
–
BLRD VA I01 BX001484BLRD VA I01 BX001991NCI NIH HHS P01 CA163200NIAAA NIH HHS P50 AA011999NIAAA NIH HHS R24 AA012885NIAAA NIH HHS U01 AA018663NIDDK NIH HHS P01 DK098108NIDDK NIH HHS P30 DK048522NIDDK NIH HHS R01 DK069418
6 · The paper itself

Abstract

In three-dimensional extracellular matrix, mesenchymal cells including hepatic stellate cells (HSCs) gain the ability to express matrix metalloproteinases (MMPs) on injury signals. In contrast, in myofibroblastic HSCs in fibrotic liver, many MMP genes are silenced into an epigenetically nonpermissive state. The mechanism by which the three-dimensional extracellular matrix confers the MMP genes into an epigenetically permissive state has not been well characterized. In continuation of previous work, we show here that the up-regulation of MMP genes is mediated through degradation of class IIa histone deacetylases (HDACs) by certain cysteine cathepsins (Cts). In three-dimensional extracellular matrix culture, CtsH, among other cysteine cathepsins, was up-regulated and localized as puncta in the nuclear and cytoplasmic compartments in a complex with HDAC4 for its degradation. Conversely, along with HSC trans-differentiation, CtsH and CtsL were progressively down-regulated, whereas HDAC4 was concurrently stabilized. The inhibition of cysteine cathepsins by specific proteinase inhibitors or chloroquine, which raises cellular pH, restored HDAC4. Recombinant CtsH could break down HDAC4 in the transfected cells and in vitro at acidic pH. In human cirrhotic liver, activated HSCs express high levels of class IIa HDACs but little CtsH. We propose that cysteine cathepsin-mediated degradation of class IIa HDACs plays a key role in the modulation of MMP expression/suppression and HSC functions in tissue injury and fibrosis.

Indexed as

Epigenesis, GeneticProteolysisAnimalsBiocatalysisCathepsin HCathepsin LCell LineCell NucleusCell TransdifferentiationDown-RegulationEnzyme StabilityExtracellular MatrixHepatic Stellate CellsHistone DeacetylasesHumansLiver CirrhosisCathepsin HCathepsin LHDAC4 protein, humanHDAC4 protein, ratHistone DeacetylasesMatrix Metalloproteinase 13Matrix Metalloproteinase 9Recombinant ProteinsRepressor ProteinsRNA, MessengerTumor Necrosis Factor-alpha

Identifiers

PMID28157489
PMCPMC5397721
OpenAlexW2584527371

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.